ATLAS / Macro Radar / Reporting / CRDF

Cardiff Oncology, Inc. (CRDF) reporting calendar

Cardiff Oncology, Inc. files periodic reports with the SEC as CRDF on Nasdaq. Atlas tracks 57 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 21 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
57

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CRDF market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001213037-26-000011
10-K31 Dec 202524 Feb 202655 days0001193125-26-067464
10-Q30 Sep 20256 Nov 202537 days0001193125-25-269424
10-Q30 Jun 202529 Jul 202529 days0000950170-25-099610
10-Q31 Mar 20258 May 202538 days0000950170-25-066886
10-K31 Dec 202427 Feb 202558 days0000950170-25-028992
10-Q30 Sep 20247 Nov 202438 days0000950170-24-123242
10-Q30 Jun 20248 Aug 202439 days0001628280-24-036098
10-Q31 Mar 20242 May 202432 days0001628280-24-019974
10-K31 Dec 202329 Feb 202460 days0001628280-24-007948
10-Q30 Sep 20232 Nov 202333 days0001628280-23-036375
10-Q30 Jun 20239 Aug 202340 days0001628280-23-028549
10-Q31 Mar 20234 May 202334 days0001628280-23-015692
10-K31 Dec 20222 Mar 202361 days0001628280-23-006037
10-Q30 Sep 20223 Nov 202234 days0001628280-22-028164
10-Q30 Jun 20224 Aug 202235 days0001628280-22-021044
10-Q31 Mar 20225 May 202235 days0001628280-22-012614
10-K31 Dec 202124 Feb 202255 days0001628280-22-003808
10-Q30 Sep 20214 Nov 202135 days0001628280-21-021747
10-Q30 Jun 20215 Aug 202136 days0001628280-21-015834
10-Q31 Mar 20216 May 202136 days0001628280-21-009283
10-K31 Dec 202025 Feb 202156 days0001628280-21-003277
10-Q30 Sep 20205 Nov 202036 days0001628280-20-015726
10-Q30 Jun 202011 Aug 202042 days0001628280-20-012428
10-Q31 Mar 20207 May 202037 days0001628280-20-006938
10-K31 Dec 201927 Feb 202058 days0001628280-20-002424
10-Q30 Sep 20197 Nov 201938 days0001628280-19-013646
10-Q30 Jun 20198 Aug 201939 days0001628280-19-010441
10-Q31 Mar 20197 May 201937 days0001628280-19-006051
10-K31 Dec 20186 Mar 201965 days0001628280-19-002546
10-Q30 Sep 20187 Nov 201838 days0001628280-18-013880
10-Q30 Jun 20183 Aug 201834 days0001628280-18-010424
10-Q31 Mar 20188 May 201838 days0001628280-18-006233
10-K31 Dec 201726 Feb 201857 days0001628280-18-002226
10-Q30 Sep 20179 Nov 201740 days0001628280-17-011252
10-Q30 Jun 20179 Aug 201740 days0001628280-17-008455
10-Q31 Mar 201710 May 201740 days0001628280-17-005344
10-K31 Dec 201615 Mar 201774 days0001628280-17-002601
10-Q30 Sep 20169 Nov 201640 days0001628280-16-021098
10-Q30 Jun 20164 Aug 201635 days0001628280-16-018502

Source: SEC EDGAR company submissions for CIK 0001213037. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.